Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 7
Lung Cancer: Targets and Therapy
ISSN: 1179-2728
- View all (178)
- Volume 15, 2024 (6)
- Volume 14, 2023 (12)
- Volume 13, 2022 (8)
- Volume 12, 2021 (14)
- Volume 11, 2020 (11)
- Volume 10, 2019 (16)
- Volume 9, 2018 (14)
- Volume 8, 2017 (25)
- Volume 7, 2016 (17)
- Volume 6, 2015 (9)
- Volume 5, 2014 (10)
- Volume 4, 2013 (9)
- Volume 3, 2012 (9)
- Volume 2, 2011 (6)
- Volume 1, 2010 (12)
Archive: Volume 7, 2016
Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer
Legius B, Van Den Broecke S, Muylle I, Ninane V
Lung Cancer: Targets and Therapy 2016, 7:149-152
Published Date: 30 November 2016
Lung cancer in Brazil: epidemiology and treatment challenges
de Sá VK, Coelho JC, Capelozzi VL, Azevedo SJ
Lung Cancer: Targets and Therapy 2016, 7:141-148
Published Date: 14 November 2016
Oligometastatic non-small-cell lung cancer: current treatment strategies
Richard PJ, Rengan R
Lung Cancer: Targets and Therapy 2016, 7:129-140
Published Date: 4 November 2016
Radiation-induced esophagitis in lung cancer
Baker S, Fairchild A
Lung Cancer: Targets and Therapy 2016, 7:119-127
Published Date: 13 October 2016
Electromagnetic navigation bronchoscopy: clinical utility in the diagnosis of lung cancer
Seijo LM
Lung Cancer: Targets and Therapy 2016, 7:111-118
Published Date: 12 October 2016
Outcomes and prognostic factors of chemotherapy for patients with locally advanced or metastatic pulmonary squamous cell carcinoma
Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Lung Cancer: Targets and Therapy 2016, 7:99-110
Published Date: 24 August 2016
Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer
Tran PN, Klempner SJ
Lung Cancer: Targets and Therapy 2016, 7:91-97
Published Date: 18 July 2016
Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
Giroux Leprieur E, Fallet V, Cadranel J, Wislez M
Lung Cancer: Targets and Therapy 2016, 7:83-90
Published Date: 17 June 2016
Fatigue in lung cancer patients: symptom burden and management of challenges
Carnio S, Di Stefano RF, Novello S
Lung Cancer: Targets and Therapy 2016, 7:73-82
Published Date: 9 May 2016
Modern management of malignant pleural mesothelioma
Patel SC, Dowell JE
Lung Cancer: Targets and Therapy 2016, 7:63-72
Published Date: 3 May 2016
High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells
Tian H, Li X, Jiang W, Lv C, Sun W, Huang C, Chen R
Lung Cancer: Targets and Therapy 2016, 7:53-61
Published Date: 2 May 2016
Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
Sawada S, Suehisa H, Ueno T, Sugimoto R, Yamashita M
Lung Cancer: Targets and Therapy 2016, 7:45-51
Published Date: 27 April 2016
Retrospective analysis of outcomes and prognostic factors of chemotherapy for small-cell lung cancer
Minami S, Ogata Y, Ihara S, Yamamoto S, Komuta K
Lung Cancer: Targets and Therapy 2016, 7:35-44
Published Date: 5 April 2016
Optimal delivery of follow-up care following pulmonary lobectomy for lung cancer
Chen YY, Huang TW, Chang H, Lee SC
Lung Cancer: Targets and Therapy 2016, 7:29-34
Published Date: 30 March 2016
miRNA-21 as a novel therapeutic target in lung cancer
Markou A, Zavridou M, Lianidou ES
Lung Cancer: Targets and Therapy 2016, 7:19-27
Published Date: 2 March 2016
HSP90 as a novel molecular target in non-small-cell lung cancer
Esfahani K, Cohen V
Lung Cancer: Targets and Therapy 2016, 7:11-17
Published Date: 1 March 2016
Nutrition support and dietary interventions for patients with lung cancer: current insights
Kiss N
Lung Cancer: Targets and Therapy 2016, 7:1-9
Published Date: 27 January 2016